Health
FDA Flags Potential Vision Loss Risk for Popular GLP-1 Diabetes and Weight Loss Drugs
FDA advises that Ozempic, Zepbound, and other GLP-1 drugs carry a potential risk of vision loss, including non-arteritic anterior ischemic optic neuropathy.